The pharmaceutical industry is undergoing a fundamental shift. The pharma markets in the U.S. and Europe are leading this tech-related disruption. These markets are expected to be worth $635 billion and $315 billion in sales respectively by 2024. As a result of the industry’s digital transformation, less money is being spent on R&D. Between 2013 and 2021, major pharmaceutical companies introduced 106 new drugs, investing an average of $2.8 billion in research and development and regulatory approval. It is possible to find cheap pharmaceutical stocks to invest in for 2022, such as Agile Therapeutics, Inc. (AGRX) and Kaleido Biosciences, Inc.
Here is Insider Monkey’s list of 10 cheap pharmaceutical stocks for 2022. Collegium Pharmaceutical, Inc. is a specialty pharma firm that concentrates on the development of medicines for pain management. As of February 14, BioDelivery Sciences International was acquired by the company in a deal worth $604 million. Pharmaceutical products are manufactured and sold by Takeda Pharmaceutical Company Limited. It was developed for routine prophylaxis in patients with Willebrand disease. Vonvendi is an oral therapeutic There are approximately three million people in the United States who suffer from this blood disorder, making it one of the most common. Restasis, a drug that reduces inflammation in the tear glands, has been given FDA approval for a generic version by Viatris Inc. ABbVie developed Restasis, a popular anti-aging drug. There is a biopharmaceutical company called Dynavax Technologies Corporation that focuses on the development of vaccines. According to Goldman Sachs analyst Madhu Kumar, the stock received a buy rating and a $38 price target as recently as January 5. On the stock market is a Boston-based healthcare company called Ironwood Pharmaceuticals Inc. In 2021, Linzess sales in the United States are expected to exceed $1 billion. It also stated that the company repurchased $27 million worth of shares in the fourth quarter of 2021. For more details, click 10 Cheap Pharmaceutical Stocks For 2022.